PlexBio Co., Ltd.

PlexBio Co., Ltd. is a health technology company focused on the research, development, manufacturing, and sale of advanced medical testing equipment and reagent solutions. The company specializes in providing diversified platforms for in vitro diagnostics, offering companion diagnostic kits, genotyping and detection assays, nucleic acid extraction kits, and research reagents critical for molecular and clinical laboratories. PlexBio’s product portfolio features fluorescence analyzers, automated code processors, molecular assay systems, immunoassay automation, and Trio nucleic acid extraction systems, targeting a wide spectrum of clinical and research needs in disease detection and personalized medicine. Established in 2009 and headquartered in Taipei, the company operates at the intersection of healthcare and biotechnology, holding an important role in supporting diagnostics innovation. PlexBio is recognized for its contribution to the healthcare equipment and supplies sector by supplying essential tools that support laboratories and clinicians in improving diagnostic accuracy, efficiency, and reliability, reinforcing its significance within the broader medical device and life sciences markets.